IndraLab

Statements



No evidence text available

No evidence text available

reach
"Notably, baricitinib, at a high dose, also inhibits Tyk2, which mediates IL-10, IL-12/23, IL-6, and IL-4/13 signaling."

No evidence text available

No evidence text available

No evidence text available